In a groundbreaking study, researchers from ETH Zurich have unveiled a novel method for delivering drugs directly into cells using microbubbles and ultrasound. This innovative technique could revolutionize the treatment of brain diseases such as Alzheimer's, Parkinson's, and brain tumors by overcoming the blood-brain barrier. The team, led by Professor Outi Supponen, has visualized how microbubbles generate microscopic liquid jets that penetrate cell membranes, allowing drugs to enter cells without causing damage. This discovery provides valuable insights into the mechanics of targeted drug delivery, potentially leading to safer and more effective therapies.
In a remarkable advancement, scientists at ETH Zurich have demonstrated how microbubbles can be used to deliver drugs into cells through the application of ultrasound. In their study, published in Nature Physics, the researchers showed that when exposed to ultrasound, these tiny gas-filled bubbles transform into powerful liquid jets capable of creating minute pores in cell membranes. These jets move at speeds of up to 200 kilometers per hour, enabling precise drug delivery without harming the cells.
The research team, headed by Professor Outi Supponen from the Institute of Fluid Dynamics, conducted experiments using an in-vitro model of the blood vessel wall. They observed that under specific ultrasound pressures, the microbubbles change shape, generating lobes that oscillate and produce high-speed jets. These jets can perforate cell membranes, allowing drugs to enter the cells efficiently. Importantly, this process occurs at relatively low ultrasound pressures, comparable to atmospheric pressure, making it safe for clinical applications.
To achieve these observations, the researchers developed a specialized microscope setup capable of capturing the rapid movements of microbubbles at up to ten million frames per second. This allowed them to visualize the interaction between microbubbles and cells from a side-on perspective, revealing the formation of microjets in unprecedented detail.
This breakthrough not only advances our understanding of the physical mechanisms behind targeted drug delivery but also paves the way for safer and more effective treatments. By optimizing the frequency, pressure, and size of microbubbles, clinicians can maximize therapeutic outcomes while minimizing risks to patients. Moreover, the findings suggest that just a few pulses of ultrasound are sufficient to create the necessary pores in cell membranes, reducing the duration and intensity of treatment.
Professor Supponen emphasizes the significance of this research, stating that it clarifies the physical foundations for targeted drug administration and helps define criteria for safe and effective use. The ability to observe and understand microbubble behavior opens new avenues for refining microbubble formulations and enhancing their performance in various medical applications. Ultimately, this work represents a major step forward in the field of medical physics, offering hope for improved treatments for some of the most challenging neurological conditions.